Key facts
- Notable investors include Entrada Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Azulene Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Azulene Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Azulene Labs
Developer of a predictive modeling platform designed to accelerate discovery in chemistry and materials science. The company's platform utilizes artificial intelligence, machine learning algorithms, molecular simulations and property forecasting, enabling researchers to optimize material performance, enhance drug design and drive innovation in pharmaceuticals and structural engineering.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Website
- azulenelabs.com/
- Ownership
- Privately Held (backing)
Azulene Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Azulene Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Azulene Labs in its N-PORT filings yet. We sweep new filings monthly.